Use of Vasopressin Following the Fontan Operation

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Pleural Effusion, Single-ventricle

In brief

The purpose of this pilot study is to prepare for a larger study to determine whether Vasopressin following the Fontan operation will decrease chest tube output and duration.

Key facts

Study ID

NCT02975999

Run by

Wake Forest University Health Sciences

People needed

12

Starts

2016-12-01

Expected to finish

2019-12-01

Last updated by the study team

2024-10-24

Who can join

Age: 2 and older, up to 7. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects between 1.5-7 years old undergoing Fontan operation.

You may not qualify if…

• Patients with a planned fenestrated Fontan.
• Patients undergoing revision surgery for failing Fontan.
• Evidence of renal insufficiency prior to surgery defined by creatinine >1 mg/dl.
• Planned arch reconstruction at the time of the Fontan procedure

Where it is running

• Advocate Children's Hospital — Oak Lawn, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.